Related Experiment Video
Updated: May 21, 2026

Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer
Published on: February 13, 2019
Cardiac transcription factor Nkx2.5 is downregulated under excessive O-GlcNAcylation condition
Hoe Suk Kim1, Ji Soo Woo, Hyun Jung Joo
1The Institute of Radiation Medicine, Medical Research Center, Seoul National University, Jongno-gu, Seoul, Korea.
Abstract:
Post-translational modification of proteins with O-linked N-acetylglucosamine (O-GlcNAc) is linked the development of diabetic cardiomyopathy. We investigated whether Nkx2.5 protein, a cardiac transcription factor, is regulated by O-GlcNAc. Recombinant Nkx2.5 (myc-Nkx2.5) proteins were reduced by treatment with the O-GlcNAcase inhibitors STZ and O-(2-acetamido-2-deoxy-D-glucopyroanosylidene)-amino-N-phenylcarbamate; PUGNAC) as well as the overexpression of recombinant O-GlcNAc transferase (OGT-flag). Co-immunoprecipitation analysis revealed that myc-Nkx2.5 and OGT-flag proteins interacted and myc-Nkx2.5 proteins were modified by O-GlcNAc. In addition, Nkx2.5 proteins were reduced in the heart tissue of streptozotocin (STZ)-induced diabetic mice and O-GlcNAc modification of Nkx2.5 protein increased in diabetic heart tissue compared with non-diabetic heart. Thus, excessive O-GlcNAcylation causes downregulation of Nkx2.5, which may be an underlying contributing factor for the development of diabetic cardiomyopathy.
Insights
Excessive O-linked N-acetylglucosamine (O-GlcNAc) modification of Nkx2.5 protein reduces its levels, contributing to diabetic cardiomyopathy development.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Research
Background:
- Diabetic cardiomyopathy is linked to O-linked N-acetylglucosamine (O-GlcNAc) protein modification.
- Nkx2.5 is a crucial cardiac transcription factor implicated in heart development and function.
Purpose of the Study:
- To investigate the regulatory role of O-GlcNAc modification on Nkx2.5 protein.
- To determine if Nkx2.5 is a direct target of O-GlcNAc transferase (OGT) and O-GlcNAcase (OGC).
Main Methods:
- Recombinant Nkx2.5 protein was treated with O-GlcNAcase inhibitors (STZ, PUGNAC) and OGT overexpression.
- Co-immunoprecipitation assays were used to detect interactions between Nkx2.5 and OGT.
- Nkx2.5 modification by O-GlcNAc was assessed in vitro and in vivo using diabetic mouse models.
Main Results:
- O-GlcNAc modification reduced recombinant Nkx2.5 protein levels.
- Nkx2.5 directly interacted with OGT, indicating O-GlcNAc modification.
- Nkx2.5 protein levels were decreased, while O-GlcNAc modification was increased in the hearts of diabetic mice.
Conclusions:
- Excessive O-GlcNAcylation leads to Nkx2.5 downregulation.
- Nkx2.5 downregulation by O-GlcNAc modification is a potential mechanism contributing to diabetic cardiomyopathy.
Related Concept Videos
Cell Specific Gene Expression
Master Transcription Regulators
General Transcription Factors
GPCRs Regulate Adenylyl Cylase Activity
Two...
Co-activators and Co-repressors
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
